, a prominent provider of artificial intelligence (AI) solutions for medical imaging, has officially launched Augmento X-Ray, a revolutionary Computer-Aided Detection (CADe) Chest X-Ray AI solution. The announcement was made at the Radiology Society of North America’s (RSNA) 109th Annual Meeting, the world’s largest radiology conference. Augmento X-Ray, powered by US FDA Cleared CXR AI, is designed to significantly alleviate the workload of radiologists and enhance the quality of chest X-ray reporting.

Chest radiography is a widely used medical imaging tool for routine clinical practices, particularly for identifying various disease findings. Given the staggering volume of 3.5 billion annual X-rays, with 1.5 billion dedicated to chest examinations, the demand for precise interpretation is critical., headquartered in India, has already made a substantial impact in the healthcare sector, particularly in India and the Asia-Pacific region. The company’s AI solutions are deployed in over 500 hospitals and imaging centers, positively influencing the lives of more than a million individuals annually. Notably,’s platform, Augmento Enterprise, which is US FDA-approved, has been selected as the national radiology AI platform in Singapore, contributing to enhanced productivity and the quality of care in public hospitals.

With a team of approximately 200 members and partnerships with organizations like TATA Capital, NTT DATA Japan, and Shimadzu Asia Pacific, has established itself as a key player in the medical AI space.

As sets its sights on entering the US market, the launch of Augmento X-Ray, coupled with US FDA approvals, positions the company to make a significant impact on the global healthcare landscape. The innovative AI solution reflects’s commitment to advancing medical imaging and providing valuable support to radiologists, ultimately improving patient outcomes.

By Admin

Leave a Reply

Your email address will not be published. Required fields are marked *